These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5589021)

  • 21. [A case of polyvisceral thesaurismosis caused by polyvinyl pyrrolidone].
    Moinade S; Terrasse J; Vilatte A
    Ann Med Interne (Paris); 1977 Feb; 128(2):183-7. PubMed ID: 326119
    [No Abstract]   [Full Text] [Related]  

  • 22. Localized cutaneous polyvinylpyrrolidone storage disease mimicking cheilitis granulomatosa.
    Chi CC; Wang SH; Kuo TT
    J Cutan Pathol; 2006 Jun; 33(6):454-7. PubMed ID: 16776723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paradoxal hypercalcemic effect of corticoids in a patient under hemodialysis with polyvinylpyrrolidone (PVP) thesaurismus].
    Richard-Mendes da Costa C; Dupont E; Thoua Y; Vanherweghem JL; Potvliege P; Libert J; Verbeelen D; Toussaint C
    J Urol Nephrol (Paris); 1977; 83(4-5):293-6. PubMed ID: 894785
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mandibular localization of thesaurismosis (polyvinyl-pyrrolidine) (author's transl)].
    Tereau Y; Vonnet A; Matar A; Brocheriou C
    Rev Stomatol Chir Maxillofac; 1978; 79(1):91-7. PubMed ID: 276910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary miliaria: caused by thesaurismosis or allergy?].
    Duverne J; Volle H; Perret MJ; Lagnier H; Bérard J
    J Fr Med Chir Thorac; 1971 Jan; 25(1):69-73. PubMed ID: 5553090
    [No Abstract]   [Full Text] [Related]  

  • 26. [Case of polyvinylpyrrolidone thesaurismosis of the endometrium].
    Kamei K; Ono T; Shiozuka Y; Shimizu S; Murakami N
    Sanfujinka No Jissai; 1969 Jul; 18(7):677-81. PubMed ID: 5307951
    [No Abstract]   [Full Text] [Related]  

  • 27. [Polyvinylpyrrolidone (PVP) storage disease involving skin and bone. Chemical analysis of PVP from human skin and serum (author's transl)].
    Mukai H
    Nihon Hifuka Gakkai Zasshi; 1982 Jan; 92(1):41-6. PubMed ID: 6978955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thesaurismosis caused by polyvinylpyrrolidone (PVP) with eosinophilic bronchopulmonary involvement].
    Delaunois L; Bosly A
    Acta Clin Belg; 1983; 38(4):253-7. PubMed ID: 6637324
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bone polyvinylpyrrolidone storage disease associated with Insulosan. Apropos of a case].
    Trèves R; Leboutet MJ; Loubet A; Tournier C; Pillegand B; Claude R; Dibon JM; Pecout C; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):479-82. PubMed ID: 7051259
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the excretion of polyvinylpyrrolidone and some toxins from the body].
    From AA; Giul'badamova NM; Suzdaleva VV; Sipotenko AV
    Probl Gematol Pereliv Krovi; 1965 Jul; 10(7):34-7. PubMed ID: 5858673
    [No Abstract]   [Full Text] [Related]  

  • 31. [Elimination and retention of various polyvinylpyrrolidone types in the body].
    AMMON R; DEPNER E
    Z Gesamte Exp Med; 1957; 128(6):607-28. PubMed ID: 13456703
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term studies on the effect of polyvinylpyrrolidone retention in human patients.
    ALTEMEIER WA; SCHIFF L; GALL EA; GIUSEFFI J; HAMILTON D; FREIMAN D; BRAUNSTEIN H
    Surg Forum; 1953 Oct; 4():724-30. PubMed ID: 13187374
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered polyvinylpyrrolidone clearance and immune responsiveness caused by small dietary changes.
    Newby TJ; Stokes CR; Bourne FJ
    Clin Exp Immunol; 1980 Feb; 39(2):349-54. PubMed ID: 6993070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fecal excretion of polyvinylpyrrolidone I-131 in hepatic cirrhosis].
    Olarte JA; Sachetto R; Vilariño J; Rubio HH; Fernández FJ
    Prensa Med Argent; 1965 Apr; 52(14):826-9. PubMed ID: 5831113
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the urinary elimination of polyvinylpyrrolidone by means of perfusion of the isolated kidney and with intact dogs].
    BESSE JH
    Therapie; 1954; 9(6):685-90. PubMed ID: 14373612
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous manifestations of metabolic diseases: uncommon presentations.
    Köstler E; Porst H; Wollina U
    Clin Dermatol; 2005; 23(5):457-64. PubMed ID: 16179179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The retention by the body of 131-I-polyvinylpyrrolidone and its effect on radiation dose.
    Tothill P
    J Nucl Med; 1965 Aug; 6(8):582-7. PubMed ID: 5831328
    [No Abstract]   [Full Text] [Related]  

  • 38. [The transfer of large molecules from the blood into the bile and hepatic lymph in the guinea-pig. Study on polyvinylpyrrolidone-I-131].
    CHENDEROVITCH J; PHOCAS E; TROUPEL S; RENAULT H; CAROLI J
    Rev Fr Etud Clin Biol; 1961 May; 6():470-2. PubMed ID: 13692780
    [No Abstract]   [Full Text] [Related]  

  • 39. The immobilization of gossypol derivative on N-polyvinylpyrrolidone increases its water solubility and modifies membrane-active properties.
    Ionov M; Gordiyenko N; Olchowik E; Baram N; Zijaev K; Salakhutdinov B; Bryszewska M; Zamaraeva M
    J Med Chem; 2009 Jul; 52(14):4119-25. PubMed ID: 19603832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Skin infiltration by polyvinylpyrrolidone].
    Cabanne F; Chapuis JL; Duperrat B; Putelat R
    Ann Anat Pathol (Paris); 1966; 11(4):385-96. PubMed ID: 5972271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.